First human trial launches for new lupus injection

NCT ID NCT05835986

Summary

This is the first study in people to test a new injectable drug called RO7507062 for systemic lupus erythematosus (SLE). The main goal is to check the drug's safety, side effects, and how it moves through the body in about 70 participants with active lupus. Researchers will test different doses to find a safe and tolerable level for future studies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CREA Hospital Mexico Americano

    RECRUITING

    Guadalajara, Jalisco, 44620, Mexico

  • Centre For Human Drug Research

    ACTIVE_NOT_RECRUITING

    Leiden, 2333, Netherlands

  • Chang Gung Medical Foundation - Linkou

    RECRUITING

    Taoyuan District, 333, Taiwan

  • Charité Research Organisation GmbH

    RECRUITING

    Berlin, 10117, Germany

  • Chung Shan Medical University Hospital

    RECRUITING

    Taichung, 40201, Taiwan

  • Clinica De La Costa

    RECRUITING

    Barranquilla, 080020, Colombia

  • Clínica San Juan Bautista CSJB

    RECRUITING

    Lima, 15431, Peru

  • FARMOVS (Pty) Ltd

    RECRUITING

    Bloemfontein, 9301, South Africa

  • Groupe Hospitalier Pitie-Salpetriere

    RECRUITING

    Paris, 75651, France

  • Hospital Angeles De Lindavista

    RECRUITING

    Mexico City, Mexico CITY (federal District), 07760, Mexico

  • Hospital General De Mexico

    RECRUITING

    Mexico City, Mexico CITY (federal District), 6726, Mexico

  • Hospital General Universitario Gregorio Marañon

    RECRUITING

    Madrid, 28007, Spain

  • Hospital Pablo Tobon Uribe

    RECRUITING

    Medellín, 050034, Colombia

  • Hospital Umum Sarawak

    RECRUITING

    Kuching, 93586, Malaysia

  • Hospital Universitario 12 de Octubre

    RECRUITING

    Madrid, 28041, Spain

  • Hospital Universitario Reina Sofia

    RECRUITING

    Córdoba, 14004, Spain

  • Hôpital Saint Eloi

    RECRUITING

    Montpellier, 34295, France

  • MICS Centrum Medyczne Damiana, Walbrzyska

    WITHDRAWN

    Warsaw, 02-739, Poland

  • Oncomedica S.A.

    RECRUITING

    Montería, 230002, Colombia

  • Ramathibodi Hospital, Mahidol Uni

    RECRUITING

    Bangkok, 10400, Thailand

  • UCL Hospital NHS Trust

    RECRUITING

    London, NW1 2PG, United Kingdom

  • Universitätsklinikum Duesseldorf

    RECRUITING

    Düsseldorf, 40225, Germany

  • Uniwersytecki Szpital Kliniczny w Poznaniu

    RECRUITING

    Późna, 61-848, Poland

  • Wojskowy Instytut Medyczny- Panstwowy Instytut Badawczy

    RECRUITING

    Warsaw, 04-141, Poland

Conditions

Explore the condition pages connected to this study.